CG:603882 Guangzhou Kingmed Diagnostics Grou

Guangzhou Kingmed Diagnostics Group Co., Ltd. operates as a third-party medical laboratory company in China. The company offers medical examination, clinical trial, food and hygiene testing, and scientific research services. As of January 3, 2019, it operated 37 testing laboratories with approximately 2,400 testing items to serve approximately 21,000 medical institutions. The company has a strategic partnership with Personal Genome Diagnostics Inc. to serve the clinical trial screening needs of pharmaceutical partners in the Asian market. The company was founded in 1994 and is headquartered in Guangzhou, China.

77.72 CNY
As of 01/28/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  China
Country of incorporation:  China
IPO date:  09/08/2017
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   36,525,219,840 CNY
Current dividend yield:   0.40%
Sedol:      BFYX689

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy